期刊文献+

短程小剂量口服激素在婴幼儿喘息急性期联合降阶梯治疗方案中的作用研究 被引量:8

Effect of Low-Dose and Short-Term Oral Corticosteroid in the Combine-Counter Gradient Therapy for Infants Wheezing
下载PDF
导出
摘要 目的:前期研究表明,与目前常用的静脉激素及抗生素治疗方案相比,由泼尼松+阿奇霉素+妥洛特罗贴剂+氯雷他定+孟鲁司特钠组成的联合降阶梯治疗方案对婴幼儿喘息具有更好的疗效。在此基础上,本研究将进一步探讨作为联合降阶梯治疗方案组分之一的泼尼松在其中的作用。方法:选取2011年10-12月来我院哮喘门诊就诊的婴幼儿喘息患儿,共计100例,随机分为泼尼松组和对照组各50例。泼尼松组用药方案:泼尼松0.5 mg/(kg·d)×3 d,每天1次晨顿服;阿奇霉素10 mg/(kg·d)×3d,每天1次口服;妥洛特罗贴剂0.5 mg/d(1贴)×7 d;氯雷他定糖浆3 mL/d×14 d,每天1次口服;孟鲁司特钠4 mg/d×14 d,每天1次口服。对照组除无泼尼松外,其他药物用法用量同泼尼松组。结果:(1)两组在治疗第3天和第7天咳嗽、喘息、哮鸣音症状均较治疗前好转。(2)泼尼松组在治疗第3天咳嗽、哮鸣音症状评分以及临床疗效均优于对照组(P<0.05)。结论:短程小剂量口服激素是婴幼儿喘息急性期联合降阶梯治疗方案的有效组分之一。 Objective: Previous studies suggested combine-counter gradient therapy with prednisone, azithromycin, tulobuterol patch, loratadine and montelukast has better efficacy than intravenous corticosteroid and antibiotics. This study is to evaluate the efficacy of prednisone in the combine-counter gradient therapy for infants wheezing. Methods: Random allocation was taken to averagely divide 100 out-patients from October 2011 to December 2011 into two groups: combine-counter gradient therapy were received as the prednisone group. The treatment protocol of the prednisone group was oral prednisone 0.5 mg/(kg . d), qd for three days; azithromycin 10 mg/(kg . d), qd for three days; tulobuterol patch 0.5 mg/d for seven days; loratadine 0. 3 mL/(kg . d), qd for fourteen days. ; montelukast 4 mg/d, qd for fourteen days. The control group abolished prednisone, the rest of drugs were the same as the prednisone group. Results: ( 1 ) The prednisone group and the control group after treatment for three days and seven days all had therapeutic effect on respiratory symptoms ( cough, wheeze, wheezing sound) . (2) Comparisons of the two groups: cough, wheezing sound symptoms and clinical efficacy after treatment for three days were statistically significant different (P〈0.05). Conclusions: According to our research, low-dose and short-term oral prednisone should be chosen as one of the main medicine of the combine-counter gradient therapy.
出处 《儿科药学杂志》 CAS 2014年第3期9-12,共4页 Journal of Pediatric Pharmacy
基金 上海市科委生物医学重大课题资助项目(10DZ1951000)
关键词 泼尼松 婴幼儿 喘息 联合降阶梯 Prednisone Infants Wheeze Combine-counter gradient
  • 相关文献

参考文献15

  • 1Lima JA, Fischer GB, Sarria EE, et al. Prevalence of and risk factors for wheezing in the first year of life [Jl. J Bras Pneumol, 2010, 36(5): 525-531.
  • 2高苗苗,林芊,鲍一笑.联合降阶梯方案治疗婴幼儿喘息疗效及安全性研究[J].中国实用儿科杂志,2012,27(3):202-205. 被引量:27
  • 3中华医学会儿科学分会呼吸学组.儿童支气管哮喘防治常规(试行)[J].中华儿科杂志,2004,42(2):100-106. 被引量:2630
  • 4WHO/NHLBI Workshop Report. National Heart, Lung, and Blood Institute. Global strategy for Asthma Management and Prevention [ EB/OL]. Revised, 2010. www. ginasthma, org.
  • 5Piacentini GL, Peroni DG, Bodini A, et al. Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway irdlammation in asthmatic children: a preliminary report [ J 1. Allergy Asthma Proc, 2007, 28(2) : 194-198.
  • 6Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti- viral responses in bronchial epithelial cells [ J 1. Eur Respir J, 2010, 36(3) : 646-654.
  • 7Yoshihara S, Fukuda H, Abe T, et al. Comparative study of skin permeation profiles between brand and generic tulobuterol patches [Jl. Biol Pharm Bull, 2010, 33(10) : 1763-1765.
  • 8陈梅,刘丹.氯雷他定对儿童支气管哮喘并变应性鼻炎的防治作用及其机制的研究[J].中国全科医学,2008,11(1):18-20. 被引量:17
  • 9Nelson HS. Prospects for antihistamines in the treatment of asthma [J]. J Allergy Clin lmmunol, 2003, 112 (4 Suppl): $96-100.
  • 10Amlani S, Mclvor RA. Montelukast in childhood asthma: what is the evidence for its use [J] .9 Expert Rev Respir Med, 2011 , 5(1) : 17-25.

二级参考文献51

共引文献2707

同被引文献91

  • 1Bouzas ML, Solé D, Cardoso MR, et al. Wheezing in infants: frequency, clinical characteristics and treatment[J]. J Pediatr (Rio J), 2012,88(4): 361-365.
  • 2Bhatt JM, Smyth AR. The management of pre-school wheeze[J]. Paediatr Respir Rev, 2011,12:70-77.
  • 3Carroll WD, Srinivas J. Bronchodilators in wheezy under 2-year-olds: when and which (if any)? [J]. Arch Dis Child Educ Pract Ed,2013,98:113-118.
  • 4Gadomski AM, Brower M. Bronchodilators for bronchiolitis[J]. Cochrane Database Syst Rev, 2010,8(12):CD001266.
  • 5Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta agonist treatment of acute asthma[J]. Cochrane Database Syst Rev,2006,2:CD000052.
  • 6Katsunuma T, Ohya Y, Fujisawa T, et al. Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children[J]. Allergy Asthma Proc, 2012,33(3):28-34.
  • 7McDonald NJ, Bara AI. Anticholinergic therapy for chronic asthma[J]. Cochrane Database Syst Rev,2003,3:CD003535.
  • 8Everard M, Bara A, Kurian M,et al. Anticholinergic drugs for wheeze in children under the age of two years[J]. Cochrane Database Syst Rev,2005,3:CD001279.
  • 9Plotnick L, Ducharme F. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children[J]. Cochrane Database Syst Rev,2000,3: CD000060.
  • 10Hartling L, Bialy LM, Vandermeer B,et al. Epinephrine for bronchiolitis[J]. Cochrane Database Syst Rev,2011,6:CD003123.

引证文献8

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部